Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and clinical determinants of antipsychotic polypharmacy in psychotic patients experiencing an acute relapse and admitted to hospital stay: results from a cross-sectional and a subsequent longitudinal pilot study.
Iasevoli F, Buonaguro EF, Marconi M, Di Giovambattista E, Rapagnani MP, De Berardis D, Martinotti G, Mazza M, Balletta R, Serroni N, Di Giannantonio M, de Bartolomeis A, Valchera A. Iasevoli F, et al. Among authors: serroni n. ISRN Pharmacol. 2014 Jan 27;2014:762127. doi: 10.1155/2014/762127. eCollection 2014. ISRN Pharmacol. 2014. PMID: 24592333 Free PMC article.
Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole.
De Berardis D, Fornaro M, Serroni N, Marini S, Piersanti M, Cavuto M, Valchera A, Mazza M, Girinelli G, Iasevoli F, Perna G, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: serroni n. Recent Pat Endocr Metab Immune Drug Discov. 2014 Jan;8(1):30-7. doi: 10.2174/1872214807666131229125700. Recent Pat Endocr Metab Immune Drug Discov. 2014. PMID: 24372345 Review.
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: an exploratory study.
De Berardis D, Serroni N, Campanella D, Rapini G, Olivieri L, Feliziani B, Carano A, Valchera A, Iasevoli F, Tomasetti C, Mazza M, Fornaro M, Perna G, Di Nicola M, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: serroni n. Compr Psychiatry. 2015 Apr;58:82-7. doi: 10.1016/j.comppsych.2014.12.016. Epub 2014 Dec 30. Compr Psychiatry. 2015. PMID: 25591904 Free article.
Inflammatory markers and suicidal attempts in depressed patients: A review.
Marini S, Vellante F, Matarazzo I, De Berardis D, Serroni N, Gianfelice D, Olivieri L, Di Renzo F, Di Marco A, Fornaro M, Orsolini L, Valchera A, Iasevoli F, Mazza M, Perna G, Martinotti G, Di Giannantonio M. Marini S, et al. Among authors: serroni n. Int J Immunopathol Pharmacol. 2016 Dec;29(4):583-594. doi: 10.1177/0394632015623793. Epub 2016 Jan 4. Int J Immunopathol Pharmacol. 2016. PMID: 26729403 Free PMC article. Review.
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders.
De Berardis D, Orsolini L, Iasevoli F, Prinzivalli E, de Bartolomeis A, Serroni N, Mazza M, Valchera A, Fornaro M, Vecchiotti R, Carano A, Sepede G, Vellante F, Matarazzo I, Pompili M, Perna G, Conti C, Segura-García C, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: serroni n. Curr Pharm Des. 2016;22(33):5144-5162. doi: 10.2174/1381612822666160701084447. Curr Pharm Des. 2016. PMID: 27396597 Review.
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice.
De Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, De Lauretis I, Girinelli G, Mazza M, Valchera A, Carano A, Vellante F, Matarazzo I, Perna G, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: serroni n. CNS Spectr. 2017 Aug;22(4):342-347. doi: 10.1017/S1092852916000572. Epub 2016 Oct 5. CNS Spectr. 2017. PMID: 27702411
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.
de Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, Valchera A, Carano A, Vellante F, Marini S, Piersanti M, Perna G, Martinotti G, Di Giannantonio M. de Berardis D, et al. Among authors: serroni n. Int J Mol Sci. 2017 Feb 8;18(2):349. doi: 10.3390/ijms18020349. Int J Mol Sci. 2017. PMID: 28208695 Free PMC article. Review.
Update on the adverse effects of clozapine: focus on myocarditis.
De Berardis D, Serroni N, Campanella D, Olivieri L, Ferri F, Carano A, Cavuto M, Martinotti G, Cicconetti A, Piersanti M, Saverio Moschetta F, Di Giannantonio M. De Berardis D, et al. Among authors: serroni n. Curr Drug Saf. 2012 Feb;7(1):55-62. doi: 10.2174/157488612800492681. Curr Drug Saf. 2012. PMID: 22663959 Review.
S-Adenosyl-L-Methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study.
De Berardis D, Marini S, Serroni N, Rapini G, Iasevoli F, Valchera A, Signorelli M, Aguglia E, Perna G, Salone A, Di Iorio G, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: serroni n. ScientificWorldJournal. 2013 May 12;2013:204649. doi: 10.1155/2013/204649. Print 2013. ScientificWorldJournal. 2013. PMID: 23766680 Free PMC article. Clinical Trial.
57 results